Filter
866
Filtered Results: 866
Text search:
Jones
I.
Featured
Recommendations
77
New Publications
112
Language
Document type
No document type
418
Studies & Reports
219
Guidelines
136
Manuals
42
Fact sheets
21
Strategic & Response Plan
14
Training Material
12
Brochures
2
Situation Updates
2
Countries / Regions
Global
44
Russia
25
Western and Central Europe
20
India
18
Africa
15
Sierra Leone
13
Ukraine
13
Kenya
12
South Africa
12
Latin America and the Carribbean
12
Uganda
11
Brazil
11
Liberia
9
Syria
9
Indonesia
9
Senegal
7
Ethiopia
7
Germany
7
Middle East and North Africa
7
Asia
7
Eastern Europe
7
USA
6
Ghana
6
Nepal
6
Mozambique
6
Namibia
6
Congo, Democratic Republic of
5
Philippines
5
Malawi
5
Chile
5
Yemen
5
Burkina Faso
4
Nigeria
4
South Sudan
4
Bangladesh
4
Myanmar / Burma
4
Mali
3
Cameroon
3
Zimbabwe
3
Pakistan
3
Zambia
3
Tanzania
3
Eswatini/ Swaziland
3
Colombia
3
Madagascar
3
Eastern Europe and Central Asia
3
Southern Africa
3
Guinea
2
Afghanistan
2
China
2
Rwanda
2
Sudan
2
Benin
2
Argentina
2
Ecuador
2
Angola
2
Lesotho
2
Mexico
2
Sri Lanka
2
East and Southern Africa
2
West and Central Africa
2
South–East Asia Region
2
Paraguay
2
Canada
2
Jamaica
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Haiti
1
Iraq
1
Chad
1
Cambodia
1
Thailand
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Burundi
1
Botswana
1
El Salvador
1
Bolivia
1
Venezuela
1
Tajikistan
1
Romania
1
Vietnam
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
202
Clinical Guidelines
88
Women & Child Health
65
Public Health
50
Key Resources
33
Capacity Building
6
Pharmacy & Technologies
2
Toolboxes
Mental Health
161
COVID-19
96
Planetary Health
71
HIV
44
TB
36
NCDs
34
Caregiver
31
Disability
27
NTDs
26
Ebola
24
Conflict
16
AMR
15
Natural Hazards
12
Health Financing Toolbox
12
Rapid Response
9
Refugee
8
Specific Hazards
7
Pharmacy
7
Global Health Education
6
Zika
5
Social Ethics
5
Polio
4
Health Financing
2
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primar...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de...
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported ...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
The Fifty-first World Health Assembly adopted resolution WHA51.11 in 1998, which targets the
global elimination of trachoma as a public health problem by 2020 (1). The strategy recommended
to achieve that goal is encapsulated by the acronym “SAFE”, which represents: Surgery for
individuals wi...
En 1998, la Cinquante-et-Unième Assemblée mondiale de la Santé a adopté la résolution
WHA51.11 qui vise l’élimination mondiale du trachome en tant que problème de santé publique
à l’horizon 2020 (1). La stratégie recommandée pour atteindre cet objectif est récapitulée dans
le sig...
La quincuagésima primera Asamblea de la Salud Mundial aprobó la resolución WHA51.11 en
1998, que busca la eliminación mundial del tracoma como problema de salud pública para el 2020
(1). La estrategia recomendada para lograr ese objetivo está encapsulada por las siglas "SAFE", que
represent...
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u...
Since 2002 the distribution of external funding to reproductive, maternal, newborn, and child health (RMNCH) has become more equitable and better targeted at the poorest countries and those experiencing the highest mortality. The aid envelope is not large enough or well enough concentrated to close ...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
Strengthening resource tracking and monitorig health expanditure
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
This article analyzes the impact of the COVID-19 pandemic on foreign aid. Using examples from Canadian foreign aid, it argues that, despite the terrible toll it is exacting, the crisis has accelerated some significant positive pre-existing trends, both by destabilizing the perception of aid as flowi...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
